The OECD projects global growth to decline from 3.2% to 2.9% in the current fiscal year 2019-2020.

Rose Prince

2019-10-29 13:36:00 Tue ET

The OECD projects global growth to decline from 3.2% to 2.9% in the current fiscal year 2019-2020. This global economic growth projection represents the slowest in a decade amid substantial economic policy uncertainty due to Sino-American trade conflict resolution, Brexit, and geopolitical risks and military confrontations in East Asia and some middle east countries such as Iran and Saudi Arabia etc. A major deterioration in global economic prognosis echoes similar concerns that monetary policymakers share in the period from the Jackson Hole summit to the recent U.S. FOMC press release.

As most central banks institute dovish interest rate cuts worldwide, monetary policy institutions may lack the important key levers and instruments to cope with the next global economic recession. As a Paris institution, the OECD further warns that a no-deal Brexit would likely push the U.K. economy into an economic recession due to both trade retrenchment and foreign capital exodus. Several OECD countries need to introduce fiscal stimulus from aggressive tax credits to fresh infrastructure expenditures in order to revive their economic prospects. These global economic developments can cause adverse ripple effects on exchange rate stabilization and asset price normalization for gold, oil, and other commodities.

 


If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.

Blog+More
Federal Reserve delivers a second interest rate hike to 1.75%-2% and then expects more rate increases in late-2018.
Charlene Vos

2018-06-08 13:35:00 Friday ET

Federal Reserve delivers a second interest rate hike to 1.75%-2% and then expects more rate increases in late-2018.

The Federal Reserve delivers a second interest rate hike to 1.75%-2% and then expects subsequent rate increases in September and December 2018 to dampen inf

+See More
The world seeks to reduce medicine prices and other health care costs to better regulate big pharma.
Daisy Harvey

2019-06-07 04:02:05 Friday ET

The world seeks to reduce medicine prices and other health care costs to better regulate big pharma.

The world seeks to reduce medicine prices and other health care costs to better regulate big pharma. Nowadays the Trump administration requires pharmaceutic

+See More
Bill Gates and Warren Buffett shared their best business decisions in a 1998 panel discussion.
Laura Hermes

2017-11-13 07:42:00 Monday ET

Bill Gates and Warren Buffett shared their best business decisions in a 1998 panel discussion.

Top 2 wealthiest men Bill Gates and Warren Buffett shared their best business decisions in a 1998 panel discussion with students at the University of Washin

+See More
American allies assist AT&T and Verizon in implementing 5G telecommunication technology.
Daisy Harvey

2019-01-01 03:34:48 Tuesday ET

American allies assist AT&T and Verizon in implementing 5G telecommunication technology.

American allies assist AT&T and Verizon in implementing 5G telecommunication technology in the U.S. as such allies ban the use of HuaWei 5G telecom equi

+See More
Facebook faces a major data breach by Cambridge Analytica that has harvested information from 50 million Facebook users.
Amy Hamilton

2018-03-17 09:35:00 Saturday ET

Facebook faces a major data breach by Cambridge Analytica that has harvested information from 50 million Facebook users.

Facebook faces a major data breach by Cambridge Analytica that has harvested private information from more than 50 million Facebook users. In a Facebook pos

+See More
The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.
Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More